Rhesus monkeys infected with SIVagm can serve as an animal model for studying HIV infection and vaccine trials.
Answers are grounded in this paper and cite their sources.
May support SIVagm rhesus model for HIV; leaves open validation for human vaccine translation.
To establish an animal model for AIDS, 6 juvenile rhesus monkeys were infected intravenously with cell-free SIVagmTYO-1, 5, or 7. One animal was infected with SIV of known pathogenicity isolated from a sooty mangabey (SIVsmm). The 2 animals infected with TYO-1, 1 of 2 infected with TYO-7 and the 1 infected with SIVsmm seroconverted within 4-8 weeks after infection and infectious virus could be recovered 8-10 or 44 weeks after infection. Three of the 4 seroconverted monkeys developed a persistent lymphadenopathy 12 weeks after infection. Rhesus monkeys infected with SIVagm could serve as a model to study HIV infection and for vaccine trials.
No takes yet. Share an insight, caveat, or question.
Herchenröder et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: